U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Blood Lactate Dehydrogenase Increased, CTCAE

MedGen UID:
1634667
•Concept ID:
C4554654
•
Finding

Definition

A finding based on laboratory test results that indicate increased levels of lactate dehydrogenase in the blood specimen. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBlood Lactate Dehydrogenase Increased, CTCAE

Professional guidelines

PubMed

Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Recent clinical studies

Etiology

Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
Yin X, Zhu W, Tang X, Yang G, Zhao X, Zhao K, Jiang L, Li X, Zhao H, Wang X, Yan Y, Xing L, Yu J, Meng X, Zhao H
BMC Cancer 2024 Apr 17;24(1):486. doi: 10.1186/s12885-024-12228-3. PMID: 38632501Free PMC Article
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Diagnosis

Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Therapy

Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
Yin X, Zhu W, Tang X, Yang G, Zhao X, Zhao K, Jiang L, Li X, Zhao H, Wang X, Yan Y, Xing L, Yu J, Meng X, Zhao H
BMC Cancer 2024 Apr 17;24(1):486. doi: 10.1186/s12885-024-12228-3. PMID: 38632501Free PMC Article
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Prognosis

Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancer.
Yin X, Zhu W, Tang X, Yang G, Zhao X, Zhao K, Jiang L, Li X, Zhao H, Wang X, Yan Y, Xing L, Yu J, Meng X, Zhao H
BMC Cancer 2024 Apr 17;24(1):486. doi: 10.1186/s12885-024-12228-3. PMID: 38632501Free PMC Article
Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Clinical prediction guides

Use of LDH and autoimmune side effects to predict response to ipilimumab treatment.
Dick J, Lang N, Slynko A, Kopp-Schneider A, Schulz C, Dimitrakopoulou-Strauss A, Enk AH, Hassel JC
Immunotherapy 2016 Sep;8(9):1033-44. doi: 10.2217/imt-2016-0083. PMID: 27485076

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...